Search this site
Embedded Files
Skip to main content
Skip to navigation
Home
About Us
Bios
History
How You Can Help
Contact Us
Resources
Improving the FDA
Pharma Marketing Hub
Publications
Monthly Newsletter Column
Pharmanipulation Podcast
Pharma-Free Advocacy Groups
Teaching Tools
PharmaBait
Videos
Conferences
2021 Conference
2019 Conference
Conference Presentations
Photos
Agenda At A Glance
Venue and Accommodations
Abstract Slam
Things to Do in DC
2023 Conference
Hotel and Venue
Speakers and Abstracts
News
PharmedOut in the News
2021 News
2020 News
2019 News
2018 News
2017 News
2016 News
2015 News
2014 News
2013 News
2012 News
2011 News
2010 News
2009 News
2008 News
2007 News
Talks and Public Comments
Newsletter
2023 Newsletters
2022 Newsletters
2021 Newsletters
2020 Newsletters
2019 Newsletters
2018 Newsletters
2017 Newsletters
2016 Newsletters
2015 Newsletters
2014 Newsletters
2013 Newsletters
Pharmed Out Fodder
Advocacy
Alzheimer's and Mild Cognitive Impairment
PharmedOut On Opioids
Fodders
Journal Articles
Media Mentions
Published Works
Presentations
Menopause
Is Low Libido A Disease?
Get Pharma Out of CME
CME
Donate
Home
About Us
Bios
History
How You Can Help
Contact Us
Resources
Improving the FDA
Pharma Marketing Hub
Publications
Monthly Newsletter Column
Pharmanipulation Podcast
Pharma-Free Advocacy Groups
Teaching Tools
PharmaBait
Videos
Conferences
2021 Conference
2019 Conference
Conference Presentations
Photos
Agenda At A Glance
Venue and Accommodations
Abstract Slam
Things to Do in DC
2023 Conference
Hotel and Venue
Speakers and Abstracts
News
PharmedOut in the News
2021 News
2020 News
2019 News
2018 News
2017 News
2016 News
2015 News
2014 News
2013 News
2012 News
2011 News
2010 News
2009 News
2008 News
2007 News
Talks and Public Comments
Newsletter
2023 Newsletters
2022 Newsletters
2021 Newsletters
2020 Newsletters
2019 Newsletters
2018 Newsletters
2017 Newsletters
2016 Newsletters
2015 Newsletters
2014 Newsletters
2013 Newsletters
Pharmed Out Fodder
Advocacy
Alzheimer's and Mild Cognitive Impairment
PharmedOut On Opioids
Fodders
Journal Articles
Media Mentions
Published Works
Presentations
Menopause
Is Low Libido A Disease?
Get Pharma Out of CME
CME
Donate
More
Home
About Us
Bios
History
How You Can Help
Contact Us
Resources
Improving the FDA
Pharma Marketing Hub
Publications
Monthly Newsletter Column
Pharmanipulation Podcast
Pharma-Free Advocacy Groups
Teaching Tools
PharmaBait
Videos
Conferences
2021 Conference
2019 Conference
Conference Presentations
Photos
Agenda At A Glance
Venue and Accommodations
Abstract Slam
Things to Do in DC
2023 Conference
Hotel and Venue
Speakers and Abstracts
News
PharmedOut in the News
2021 News
2020 News
2019 News
2018 News
2017 News
2016 News
2015 News
2014 News
2013 News
2012 News
2011 News
2010 News
2009 News
2008 News
2007 News
Talks and Public Comments
Newsletter
2023 Newsletters
2022 Newsletters
2021 Newsletters
2020 Newsletters
2019 Newsletters
2018 Newsletters
2017 Newsletters
2016 Newsletters
2015 Newsletters
2014 Newsletters
2013 Newsletters
Pharmed Out Fodder
Advocacy
Alzheimer's and Mild Cognitive Impairment
PharmedOut On Opioids
Fodders
Journal Articles
Media Mentions
Published Works
Presentations
Menopause
Is Low Libido A Disease?
Get Pharma Out of CME
CME
Donate
Published Works
2020
Patient Influencers Paid By Pharmaceutical Companies Should Be Required To Disclose Industry Ties
By Judy Butler Adriane Fugh-Berman (January 2020)
There’s trouble with tramadol that patients should know
By Adriane Fugh-Berman (March 2020)
2019
Letter in support of the CDC Guideline for Prescribing Opioids for Chronic Pain
Sophie Krensky testimony in front of the DC Council on behalf of the DC Center for Rational Prescribing (DCRx) (skip to 2:02:30)
(January 2019)
Industry-funded attacks on the CDC’s opioid prescribing guideline are eroding public health
By Ben Goodwin, Judy Butler, and Adriane Fugh-Berman (June 2019)
Opioids are still overprescribed
By Judy Butler and Adriane Fugh-Berman (August 2019)
As I See It: An industry report in government clothing
By Judy Butler and Adriane Fugh-Berman
(August 2019)
Continuing Medical Education and the Marketing of Fentanyl for Breakthrough Pain: Marketing Messages in an Industry‐Funded CME Module on Breakthrough Pain
By Margaret Infeld, Alicia Bell, Clare Marlin, Stephanie Waterhouse, Nicole Uliassi, Adriane Fugh‐Berman
(March 2019)
2018
Women and the Opioid Epidemic
By Megan Whiteman, Alycia Hogenmiller, and Dr. Fugh-Berman (January/February 2018)
Rx for Change: Alternative Treatments for Chronic Pain
By Dr. Fugh-Berman and Dr. Charlea Massion (January/February 2018)
Fentanyl at Your Door: Who are Pain Groups Advocating For?
By Breon Wise, Stephanie Obiorah, Jane Kim, Joy Eckert, Sophie Krensky and Adriane Fugh-Berman (April 2018)
Dr. Fugh-Berman presented at the California Society of Addiction Medicine's conference on social psychology techniques used to manipulate physicians' therapeutic choices and overprescription of opioids. (September 2018)
Drug companies should help pay for opioid harm
By Adriane Fugh-Berman and Sophie Krensky (December 2018)
Is the opioid epidemic now the fentanyl epidemic?
By Sophie Krensky, Ben Goodwin, and Adriane Fugh-Berman (December 2018)
5 myths about opioids
By Dr. Adriane Fugh-Berman (January 2018)
2017
Rx For Change: Obfuscating Opioid Risks
By Adriane Fugh-Berman and Charlea Massion (September 2017)
Report abuse